Que Dallara compensation by year
MiniMed Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $758,269 |
| Bonus | $0 |
| Stock awards | $4,734,375 |
| Option awards | $1,800,137 |
| Non-equity incentive | $782,595 |
| Pension and deferred compensation | $0 |
| All other | $382,787 |
| Total | $8,458,163 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MiniMed Group, Inc. DEF 14A filed August 21, 2026, accession 0001140361-26-034021, and prior-year filings.
How this page was built: the MiniMed Group, Inc. filed document, accession 0001140361-26-034021. Every figure is read from that document and cited to the page and table it appears in. Filed August 21, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 281,937 | $3,721,568 | — |
| RSU | 127,609 | $1,684,439 | — |
| PSU | 83,334 | $1,100,009 | — |
| RSU | 80,842 | $1,067,114 | — |
| RSU | 57,239 | $755,555 | — |
| RSU | 51,044 | $673,781 | — |
| RSU | 11,443 | $151,048 | — |
| Option | 252,526 | — | $18.00 |
Per the Outstanding Equity Awards at Fiscal Year-End table in MiniMed Group, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments MiniMed discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Disability | $0 | $9,021,923 | $0 | $9,021,923 |
| Death | $0 | $9,021,923 | $0 | $9,021,923 |
| Retirement | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in MiniMed Group, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
MiniMed’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Que Dallara · this page | Chief Executive Officer | $8,458,163 |
| Ali Dianaty | Executive Vice President, Chief Product & Technology Officer | $2,452,377 |
| Gillian Chandrasena | Senior Vice President, Chief Human Resources Officer | $1,837,365 |
| Courtney Nelson Wills | Senior Vice President, General Counsel | $1,208,478 |
Board service
MiniMed board · FY2025How this board is paid
Company policy: MiniMed pays directors a $70,000 cash retainer and $250,000 in RSUs. As stated in MiniMed's FY2025 proxy.
The full MiniMed compensation record
free company briefThis page is one person within MiniMed's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the MiniMed proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MiniMed's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MiniMed's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.